早发性结直肠癌的治疗延迟:基于德州癌症登记的研究
早发性患者总生存优于晚发性,但治疗延迟(诊断至 definitive 治疗超过6周)与更差生存独立相关,语言障碍是可干预的延迟因素。
要点
- 早发性结直肠癌占总队列11%,中位总生存未达到,优于晚发性80个月。
- 治疗延迟与更差总生存独立相关(HR 1.29,95%CI 1.26-1.32)。
- 语言障碍与早发性结直肠癌治疗延迟相关(OR 1.45,95%CI 1.18-1.79)。
核心结论
- 早发性结直肠癌总生存优于晚发性,但治疗延迟独立关联更差生存。
- 语言障碍是早发性结直肠癌治疗延迟的可干预风险因素。
研究设计与样本
- 回顾性、基于人群的横断面研究,使用德州癌症登记2004年1月1日至2019年12月31日确诊的结直肠癌患者数据。
主要发现
- 早发性患者中位总生存未达到,晚发性患者为80个月(HR 0.56,95%CI 0.56-0.60,P<.001)。
- 多变量分析中,较高社会脆弱性指数(HR 1.22,95%CI 1.19-1.26,P<.001)和治疗延迟(HR 1.29,95%CI 1.26-1.32,P<.001)与更差总生存相关。
- 早发性患者中,治疗延迟与更差总生存相关(HR 1.35,95%CI 1.32-1.38,P<.001)。
- 控制人口学和临床因素后,语言障碍与早发性结直肠癌治疗延迟相关(OR 1.45,95%CI 1.18-1.79,P<.001)。
关键数值与推荐
- 治疗延迟定义为从组织诊断到开始 definitive 治疗超过6周。
临床怎么用
- 对早发性结直肠癌应关注治疗延迟,尤其语言障碍患者,以改善及时诊疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Incidence of early age-onset colorectal cancer (EOCRC) is increasing. Delays in initiation of definitive therapy are associated with worse outcomes in colorectal cancer (CRC), but their impact on EOCRC has not been comprehensively characterized. OBJECTIVE: To evaluate incidence of EOCRC, identify patients affected by treatment delays, and determine targetable factors contributing to delayed therapy. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based cross-sectional study analyzed data from patients diagnosed with CRC from January 1, 2004, to December 31, 2019, using the Texas Cancer Registry. Patients were classified as having either EOCRC (diagnosed age <50 years) or average age-onset colorectal cancer (AOCRC; diagnosed age ≥50 years). The data analysis was performed between August 2024 and November 2025. MAIN OUTCOMES AND MEASURES: The main outcomes were EOCRC status and treatment delays, defined as more than 6 weeks from tissue diagnosis to initiation of definitive therapy. Overall survival (OS), prevalence, impact of treatment delays, and patient-level and system-level factors associated with delayed treatment were also assessed. RESULTS: Among 112 672 patients with CRC (overall mean [SD] age, 65.4 [13.5] years; 61 570 [54.6%] male), 12 079 (11%) had EOCRC, and 100 593 (89%) had AOCRC. The cohort comprised 3111 Asian and Pacific Islander individuals (2.8%), 14 517 Black individuals (12.9%), 23 372 Hispanic individuals (20.7%), and 71 672 White individuals (63.6%). Mean (SD) age for the EOCRC cohort was younger (41.6 [5.9] years) compared to the AOCRC cohort (68.2 [11.2] years; P < .001). Compared to patients with AOCRC, patients with EOCRC were less likely to be of White race (6421 [53.2%] vs 65 251 [64.9%]; P < .001) and more likely to be of Hispanic ethnicity (3389 [28.1%] vs 19 983 [19.9%]; P < .001). Median OS for patients with EOCRC was not reached compared to patients with AOCRC at 80 months (hazard ratio [HR], 0.56; 95% CI, 0.56-0.60; P < .001). In multivariable analysis, higher Social Vulnerability Index (HR, 1.22; 95% CI, 1.19-1.26; P < .001) and treatment delays (HR, 1.29; 95% CI, 1.26-1.32; P < .001) were associated with worse OS. Median OS for patients with EOCRC was not reached in patients with or without treatment delay; however, it remained significant (HR, 1.35; 95% CI, 1.32-1.38; P < .001). After controlling for demographic and clinical factors, language barriers were associated with treatment delay in EOCRC (odds ratio, 1.45; 95% CI, 1.18-1.79; P < .001). CONCLUSIONS AND RELEVANCE: In this cross-sectional study, EOCRC was associated with improved OS compared with AOCRC; however, treatment delays were independently associated with worse survival among patients with EOCRC. Language barriers could be a potentially modifiable risk factor associated with delayed treatment and may provide an opportunity to improve timely care and outcomes in EOCRC.
引用
- Heslin RT, Whitham ZA, Pettigrew MF, et al. Treatment Delays in Early Age-Onset Colorectal Cancer. JAMA Oncol. 2026. PMID: 42241009. doi:10.1001/jamaoncol.2026.1335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。